Target intelligence / Profile preview

Penicillin-binding proteins 1b, 2, 4, 5, and 6 (Gram-negative bacteria) (PBPs (1b, 2, 4, 5, 6))

Target
PBPs (1b, 2, 4, 5, 6)
Molecular classification
Enzyme, Transferase, Hydrolase, Penicillin-binding protein family
01

Overview

Penicillin-binding proteins (PBPs) 1b, 2, 4, 5, and 6 are a subset of enzymes essential for the synthesis and maintenance of the peptidoglycan layer in Gram-negative bacteria (UniProt: P02919). PBP1b is a high-molecular-weight (HMW) bifunctional enzyme responsible for both transglycosylation and transpeptidation, while PBP2 is an HMW transpeptidase critical for maintaining the rod shape of the cell (PubMed: 22210771). The low-molecular-weight (LMW) PBPs 4, 5, and 6 primarily function as DD-carboxypeptidases that regulate the degree of peptidoglycan cross-linking by removing terminal D-alanine residues from pentapeptide precursors (PubMed: 16428406). These proteins are the molecular targets for beta-lactam antibiotics, which act as substrate analogs and form a stable acyl-enzyme complex with the active-site serine, thereby inactivating the enzyme (StatPearls: NBK545311). The inhibition of these PBPs leads to the cessation of cell wall synthesis, triggering bacterial lysis and death. Resistance to antibiotics targeting these proteins often involves mutations that decrease drug affinity or the overproduction of LMW PBPs that can sequester the drugs (PubMed: 29445124). Understanding the specific roles of these PBPs is crucial for developing new antimicrobial agents that can bypass existing resistance mechanisms in Gram-negative pathogens.

Other names
DD-transpeptidasesDD-carboxypeptidasesPeptidoglycan biosynthetic enzymesMrcB (PBP1b)MrdA (PBP2)DacB (PBP4)DacA (PBP5)DacC (PBP6)
02

Mechanism of action

Irreversible inhibition of transpeptidase and carboxypeptidase activities by covalent binding to the active-site serine, preventing peptidoglycan cross-linking and leading to bacterial cell lysis.

03

Biological functions

Peptidoglycan biosynthesisCell wall assemblyCell shape maintenanceCell divisionPeptidoglycan remodeling
04

Disease associations

Infection (Gram-negative bacterial)
05

Safety considerations

Antimicrobial resistance (e.g., PBP mutations)Hypersensitivity reactionsDisruption of host microbiotaJarisch-Herxheimer reaction
06

Interacting drugs

Amoxicillin

9 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)PBP gene mutations (e.g., mrdA, dacA)PBP expression levelsBacterial growth inhibition

Beyond the preview

Go deeper on Penicillin-binding proteins 1b, 2, 4, 5, and 6 (Gram-negative bacteria) (PBPs (1b, 2, 4, 5, 6)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding proteins 1b, 2, 4, 5, and 6 (Gram-negative bacteria) (PBPs (1b, 2, 4, 5, 6)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call